The Liver–Testis Axis: Molecular Mechanisms and Clinical Implications
International Journal of Molecular Sciences · 29.06.2026 · 27 (13) · 5873
DOI: 10.3390/ijms27135873 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.06.2026. Verfasst von Yapeng Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China. Hauptthemen laut MEDLINE: Liver, Testis, Hypogonadism, Fatty Liver. Die Arbeit nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Academy of Chinese Medical Sciences.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) and male hypogonadism (HG) are prevalent disorders that frequently coexist, suggesting a bidirectional “liver–testis axis” as a potential pathophysiological link. This review explores the mechanistic basis and clinical implications of this axis. Molecularly, metabolically stressed hepatocytes release an altered hepatokine signature—marked by reduced sex hormone-binding globulin (SHBG) and elevated fibroblast growth factor 21 (FGF21)—along with pro-inflammatory cytokines (e.g., interleukin-1 beta (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α)), which enter the systemic circulation. These factors may contribute to the impairment of Leydig cell steroidogenesis, the perturbation of blood–testis barrier integrity, and the disruption of spermatogenesis. Conversely, testicular dysfunction and subsequent testosterone deficiency promote visceral adiposity, worsen insulin resistance and amplify chronic inflammation, thereby accelerating hepatic steatosis and fibrosis. Clinically, these molecular interactions manifest as mutually worsening of MASLD and HG. Thus, the liver–testis axis establishes a framework that reveals the bidirectional crosstalk between hepatic metabolism and gonadal function, providing novel pathophysiological insights into these interconnected conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
- Graduate School of China Academy of Chinese Medical Sciences, Beijing 100700, China.
- Graduate School of Hebei University of Chinese Medicine, Shijiazhuang 050091, China.
ORCID-Profile: Wenkang Chen
Förderung
- National Natural Science Foundation of China
- China Academy of Chinese Medical Sciences
Zitieren
APA
Zhang, Y., Xu, H., Zou, H., Lin, W., Chen, W., & Zhao, J. (2026). The Liver–Testis Axis: Molecular Mechanisms and Clinical Implications. International Journal of Molecular Sciences, 27(13), 5873. https://doi.org/10.3390/ijms27135873
Vancouver
Zhang Y, Xu H, Zou H, Lin W, Chen W, Zhao J. The Liver–Testis Axis: Molecular Mechanisms and Clinical Implications. International Journal of Molecular Sciences. 2026;27(13):5873. doi:10.3390/ijms27135873
BibTeX
@article{Zhang2026,
author = {Zhang, Yapeng and Xu, Haoran and Zou, Hede and Lin, Wei and Chen, Wenkang and Zhao, Jiayou},
title = {The Liver–Testis Axis: Molecular Mechanisms and Clinical Implications},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {13},
pages = {5873},
doi = {10.3390/ijms27135873}
}
EUVIMED